Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active pharmaceutical ingredients (APIs) and critical GMP intermediates announced the acquisition of Actylis Eugene, the legacy Cascade Chemistry business based in Eugene, Oregon. With over 20 years history, the Eugene site brings a strong legacy in small-molecule API development and manufacturing, anchored by a 16,000 square-foot R&D lab facility as well as a newly constructed 30,000 square-foot manufacturing facility, equipped with state-of-the-art GMP infrastructure supporting early-phase to late-phase clinical API production.
Read the full article: Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset //
Source: https://www.businesswire.com/news/home/20260115316188/en/Agno-Pharma-Acquires-Actyliss-CDMO-Manufacturing-Asset-the-Legacy-Cascade-Chemistry-Business-based-in-Eugene-Oregon-Strengthening-Agnos-US-cGMP-API-Development-and-Manufacturing-Capabilities